73 articles in this topic
A completed pilot trial tested humanoid robots and AI predictive models to manage dementia care at home, personalizing treatment pathways.
A Phase 4 RCT tests whether one bevacizumab injection matches two combined doses for neovascular AMD outcomes over 12 months.
The EPICURO trial tests MERIVA® turmeric over 6 months to see if it protects cognition in adults with metabolic syndrome.
Small pilot study examined psilocybin's effects on brain circuits and emotion processing in healthy adults to understand abuse potential.
French pilot study tests psychedelic therapy for patients with alcohol use disorder and comorbid depression after withdrawal.
Small doses of psilocybin tested against placebo in 39 adults with major depressive disorder to assess safety and mood benefits.
Small trial tests psychedelic therapy combined with meditation for frontline healthcare providers suffering COVID-related burnout.
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Study tested whether pimavanserin could prevent return of hallucinations and delusions in dementia patients who initially responded to treatment.
King's College study tests whether simple chewing and fasting patterns can enhance cognitive function and neurogenesis in older adults.
32-person study explores how intermittent fasting affects blood vessel function and brain performance through protective pathways.
University of Arizona researchers tested psychedelic therapy for OCD symptoms in 15-person clinical trial over four years.
